Relation of plasma adiponectin levels and aortic stiffness after acute ST-segment elevation myocardial infarction. Issue 1 (March 2014)

• Record Type: Journal Article
• Authors: Reinstadler, SJ; Klug, G; Feistritzer, HJ; Mayr, A; Bader, K; Mair, J; Esterhammer, R; Schocke, M; Metzler, B
• Is Part Of: European heart journal. Volume 3:Issue 1(2014:Mar.)
• Page Start: 10
• Page End: 17
• Publication Date: 2014-03
• Subjects: Adiponectin -- aortic stiffness -- cardiac magnetic resonance -- pulse wave velocity -- ST-segment elevation myocardial infarction; 616.1205
• DOI: 10.1177/2048872613516015
• Languages: English
• ISSNs: 2048-8726

Abstract

Background: Pulse wave velocity is a measure of aortic stiffness and an independent predictor of cardiovascular morbidity and mortality. Adiponectin is involved in atherosclerosis and inflammation. In the present study we aimed to explore the association between plasma adiponectin concentrations and pulse wave velocity in the acute phase after ST-segment elevation myocardial infarction (STEMI). Methods: Forty-six consecutive STEMI patients (mean age 57±11 years) treated with primary percutaneous coronary intervention (PCI) were enrolled in this cross-sectional study. Plasma adiponectin was measured 2 days after index event by enzyme-linked immunosorbent assay. Aortic pulse wave velocity (PWV) was calculated by the transit-time method with the use of a velocity-encoded, phase-contrast cardiac magnetic resonance protocol. Results: Median plasma adiponectin concentration was 2385 ng/ml (interquartile range 1735–5403). Males had lower plasma adiponectin values than females and current smokers had lower values than non-smokers (all p <0.02). Adiponectin was significantly associated with PWV ( r =0.505, p <0.001), age ( r =0.437, p =0.002), and total cholesterol ( r =0.468, p =0.001). Multiple linear regression analysis revealed adiponectin as a predictor of PWV independently of age, sex, smoking status, total cholesterol, and N-terminal pro-B-type natriuretic peptide ( p =0.027). Conclusions: Plasma adiponectin concentrations are strongly associated with aortic stiffness in patients after acute STEMI treated with primary PCI. Our data support a possible role for adiponectin as an independent risk marker for increased aortic stiffness in STEMI patients.